Am J Health Syst Pharm. 2007;64(11):1174-1186. In the British study, 495 patients received droperidol 2.5-50 mg p.o. for the treatment of psychiatric illness and were compared with 101 healthy ...
Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...
The agency’s main drug review office cleared 50 novel medicines last year, short of 2018’s record total but on the higher end ...
According to Vertex Pharmaceuticals, approximately 300 additional people with CF are now eligible to receive treatment.
If you're interested in exploring more stocks under $20 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Stocks under $20 offer investors and ...
Chinese regulators approved the drug for the same subset of advanced, previously treated EGFR-mutated NSCLC patients in 2023.
Note :Financial Information is based on consolidated numbers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback